Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
752 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 642 (85%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
98 (10%) |
|
Overdue reports |
1 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| CLARUS | 10MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163042 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163045 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232550 |
| CLARUS | 40MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232553 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-10-04 | 2024-11-18 | 239457 |
| CLARUS | 40MG | CAPSULE | Resolved | 2024-10-29 | 2025-03-26 | 241465 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-12-03 | 2025-01-07 | 244622 |
| CLARUS | 10MG | CAPSULE | Resolved | 2025-01-21 | 2025-03-31 | 248180 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2017-11-08 | 2018-05-31 | 28619 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2021-01-05 | 2021-02-03 | 130854 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2025-01-07 | 2025-02-05 | 246904 |
| ESME 21 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51450 |
| ESME 28 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51453 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2018-12-05 | 2019-03-06 | 68756 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-05-22 | 2019-05-29 | 84512 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-06-04 | 2019-06-19 | 85557 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-01-28 | 2020-05-06 | 104512 |
| FREYA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171506 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2017-11-03 | 2019-03-21 | 28041 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53608 |
| MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 | ||
| MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53611 |
| MYLAN-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-07-03 | 2018-08-11 | 53616 |
| MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
| MYLAN-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53628 |
| MYLAN-CARVEDILOL | 25MG | TABLET | Discontinued | 2017-07-17 | 2018-02-15 | 15824 |
| MYLAN-CARVEDILOL | 3.125MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16105 |
| MYLAN-CARVEDILOL | 6.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16108 |
| MYLAN-CARVEDILOL | 12.5MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16111 |
| MYLAN-CELECOXIB | 100MG | CAPSULE | Discontinued | 2017-11-23 | 2018-07-04 | 30337 |
| MYLAN-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-04-03 | 2018-08-01 | 44830 |
| MYLAN-CIMETIDINE | 600MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16096 |
| MYLAN-CIMETIDINE | 300MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16203 |
| MYLAN-CIMETIDINE | 400MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16206 |
| MYLAN-CIMETIDINE | 800MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16211 |
| MYLAN-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-08-24 | 2017-12-02 | 20278 |